| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |